Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
1.700
-0.070 (-3.95%)
At close: Aug 25, 2025, 4:00 PM
1.682
-0.018 (-1.08%)
After-hours: Aug 25, 2025, 7:21 PM EDT
Immutep Employees
Immutep had 31 employees as of June 30, 2014.
Employees
31
Change
n/a
Growth
n/a
Revenue / Employee
$97,395
Profits / Employee
-$875,690
Market Cap
238.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2014 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IMMP News
- 26 days ago - Immutep Quarterly Activities Report Q4 FY25 - GlobeNewsWire
- 27 days ago - Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer - GlobeNewsWire
- 3 months ago - Immutep's Efti with Radiotherapy & KEYTRUDA® (pembrolizumab) Meets Primary Endpoint in Phase II for Soft Tissue Sarcoma - GlobeNewsWire
- 3 months ago - Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo - Benzinga
- 3 months ago - Immutep Limited: Surging On Positive Head And Neck Data - Seeking Alpha
- 5 months ago - Immutep to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 months ago - Immutep Quarterly Activities Report Q2 FY25 - GlobeNewsWire
- 7 months ago - Immutep Limited: Continuing To Make The Case For Eftilagimod - Seeking Alpha